已收录 268921 条政策
 政策提纲
  • 暂无提纲
M-ESLON® (retard release morphine sulphate capsules) for pain control in cancer patients
[摘要] The pain of patients who were in the terminal phase of advanced malignant tumors was successfully relieved by M-ESLON® capsules of controlled release morphine sulphate (10-30-60-100 mg). The most frequent side effects (sickness, vomiting, obstipation) were effectively controlled. The concentration of the drug in the plasma was stable, therefore the lasting pain relief was ensured.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 生理学与病理学
[关键词] side effects [时效性] 
   浏览次数:22      统一登录查看全文      激活码登录查看全文